. | . |
Turkey using drug from China for coronavirus by Staff Writers Ankara (AFP) March 23, 2020 Turkey's health minister said Monday that the country is using a drug sent from China on patients suffering from the novel coronavirus. "From this morning we have brought a special drug used in China which is claimed to have resulted in improvements in intensive care patients, cutting their time in care from 11-12 days to four days," Fahrettin Koca told reporters. He did not give more information on the drug but the anti-malarial drug chloroquine has recently been used to treat coronavirus patients in China as well as France. Some researchers have said chloroquine shows great promise, though scientists have agreed that more trials are needed to determine if the drug is really effective and safe. According to figures released late Monday, Turkey has officially recorded 1,529 coronavirus cases and 37 deaths. Koca said 50,000 rapid detection kits had arrived from China on Monday and had begun to be used, with 300,000 expected by Thursday. The minister added that the Chinese government agreed with Turkey to share information on the novel coronavirus as the two countries step up cooperation to fight against the pandemic. While Koca did not detail where the positive cases were in Turkey, he said the virus had spread across the country. He did say there were fewer than 10 cases in Turkey's Van province, which borders badly-hit Iran. He also said some health workers had caught the coronavirus, without giving figures. A further 32,000 health workers will be employed during the crisis, he told a press conference in Ankara. Koca also said that face masks produced in Turkey "will not be exported" as the country was in need. There had been speculation that Koca might announce a state of emergency, but he urged Turks to "announce their own state of emergency" as he insisted citizens adhere to measures already announced by Ankara. Turkish authorities have ordered those aged 65 and above and those with chronic illnesses to stay at home, while most public spaces have been temporarily closed.
China embarks on clinical trial for virus vaccine Beijing (AFP) March 22, 2020 China has started the first phase of a clinical trial for a novel coronavirus vaccine, records show, as the world's scientists race to find a way to combat the deadly pathogen. It comes after US health officials said last week they had started a trial to evaluate a possible vaccine in Seattle. The Chinese effort began on March 16 - the same day as the US announcement - and is expected to continue until the end of the year, according to a filing in the country's Clinical Trial Registry, dated M ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |